Bu sayfada
LGND Ligand Pharmaceuticals Incorporated - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 7, 2026
$302,96
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$177,3552 haftanın en düşüğü
$326,6352 haftanın en yükseği
Piyasa Değeri (MRQ)
$6.03B
P/E (TTM)
31.4
Hisse Başına Kâr (TTM)
$9.65
Gelir (TTM)
$291M
rozetleriniz
52 Haftlık Aralık
$177–$327
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$344
P/E
31.4
ROE
22.0%
Net Kâr Marjı
67.9%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
LGND Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$302.96
Piyasa Değeri (MRQ)
$6.03B
P/E (TTM)
31.4
Hisse Başına Kâr (TTM)
$9.65
Gelir (TTM)
$291M
ROE (TTM)
22.0%
52 Haftlık Aralık
$177–$327
LGND Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 02 Kasım 2022 | 1603-for-1000 | İleri |
| 19 Kasım 2010 | 1-for-6 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$268M2016-12-31 → 2025-12-31
Hisse Başına Kâr$6.132016-12-31 → 2025-12-31
Serbest Nakit Akışı$49M2016-12-31 → 2025-12-31
Net kar marjı67.9%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | LGND | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 31.45Y ort. ≈-87.3 | ≈-87.3 | 36.1 | Düşük değerli | |
| F/S (TTM) | 20.85Y ort. ≈9.6 | ≈9.6 | 16.5 | Aşırı değerli | |
| F/D (MRQ) | 6.25Y ort. ≈2.4 | ≈2.4 | 8.2 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 45.95Y ort. ≈31.5 | ≈31.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 45.85Y ort. ≈30.2 | ≈30.2 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 8.05Y ort. ≈4.7 | ≈4.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | LGND | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 32.6%5Y ort. ≈8.2% | ≈8.2% | 14.9% | Aynı seviyede | |
| FAVÖK Marjı (TTM) | 43.9%5Y ort. ≈29.4% | ≈29.4% | 13.0% | Aynı seviyede | |
| Vergi Öncesi Kar Marjı (TTM) | 81.9%5Y ort. ≈28.9% | ≈28.9% | 24.6% | En üst düzey | |
| Net Kâr Marjı (TTM) | 67.9%5Y ort. ≈17.5% | ≈17.5% | 19.1% | En üst düzey | |
| ROA (TTM) | 12.6%5Y ort. ≈3.5% | ≈3.5% | -9.2% | En üst düzey | |
| ROE (TTM) | 22.0%5Y ort. ≈4.6% | ≈4.6% | -50.6% | En üst düzey | |
| ROIC | 3.2%5Y ort. ≈4.1% | ≈4.1% | -10.9% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | LGND | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 31.25Y ort. ≈11.8 | ≈11.8 | 2.3 | Güçlü likidite | |
| Cari Oran (MRQ) | 30.55Y ort. ≈10.8 | ≈10.8 | 1.7 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | LGND | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 60.4%5Y ort. ≈16.7% | ≈16.7% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 11.0%5Y ort. ≈-2.5% | ≈-2.5% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 10.4% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | LGND | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.25Y ort. ≈0.2 | ≈0.2 | 0.6 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 5.55Y ort. ≈4.3 | ≈4.3 | 5.2 | Aynı seviyede | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$5.7M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Nis 3, 2007 | $9,36 | USD | ≈33.1% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
19.6%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $2.37 | $1.86 | 27.3% |
| 31 Mart 2026 | May 6, 2026 | $1.63 | $1.85 | -12.0% |
| 31 Aralık 2025 | $2.02 | $1.59 | 26.8% | |
| 30 Eylül 2025 | $3.09 | $1.96 | 57.3% | |
| 30 Haziran 2025 | $1.60 | $1.45 | 10.4% | |
| 31 Mart 2025 | $1.33 | $1.24 | 7.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $167M | $131M | $196M | $242M | $164M | $120M | $251M | $141M | $109M | $72M | $65M | |
| Cost of Revenue | · | · | · | · | · | · | · | $6M | $5M | $6M | $6M | $9M | |
| R&D Expense | $81M | $21M | $25M | $36M | $32M | $41M | $56M | $28M | $27M | $21M | $11M | $10M | |
| SG&A Expense | $92M | $79M | $53M | $70M | $47M | $60M | $42M | $38M | $29M | $28M | $25M | $23M | |
| Operating Income | $41M | $-23M | $12M | $3M | $104M | $38M | $807M | $164M | $68M | $44M | $27M | $20M | |
| Interest Expense | · | · | $656.0K | $2M | $20M | $27M | $36M | $48M | $13M | $13M | · | $5M | |
| Interest Income | $14M | $8M | $8M | $2M | $886.0K | $8M | $28M | $14M | $2M | · | · | · | |
| Other Non-op | $-89.0K | $-20M | $-2M | $4M | $-8M | $62.0K | $-4M | $-6M | $3M | $-615.0K | $2M | $2M | |
| Pretax Income | $159M | $3M | $64M | $36M | $72M | $1M | $797M | $173M | $57M | $8M | $35M | $11M | |
| Income Tax | $35M | $7M | $10M | $41M | $-4M | $-5M | $167M | $30M | $45M | $10M | $-192M | $410.0K | |
| Net Income | $124M | $-4M | $52M | $-33M | $57M | $-3M | $629M | $143M | $13M | $-2M | $230M | $12M | |
| EPS (Basic) | $6.44 | $-0.22 | $3.02 | $-1.98 | $3.44 | $-0.18 | $33.13 | $6.77 | $0.60 | $-0.08 | $11.61 | $0.59 | |
| EPS (Diluted) | $6.13 | $-0.22 | $2.94 | $-1.98 | $3.31 | $-0.18 | $31.85 | $5.96 | $0.53 | $-0.08 | $10.83 | $0.56 | |
| Shares (Basic) | 19,338,000 | 18,290,000 | 17,298,000 | 16,868,000 | 16,630,000 | 16,185,000 | 18,995,000 | 21,160,000 | 21,032,000 | 20,831,000 | 19,790,000 | 20,419,000 | |
| Shares (Diluted) | 20,294,000 | 18,290,000 | 17,757,000 | 16,868,000 | 17,246,000 | 16,825,000 | 19,757,000 | 24,067,000 | 23,481,000 | 20,831,000 | 21,228,000 | 21,433,000 | |
| EBITDA | $75M | $13M | $48M | $55M | $130M | $52M | $825M | $178M | $80M | $55M | $30M | $22M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $175M | $72M | $23M | $45M | $20M | $48M | $72M | $117M | $21M | $19M | $97M | $160M | |
| Short-term Investments | $559M | $184M | $147M | $167M | $322M | $364M | $998M | $601M | $181M | $122M | $103M | $7M | |
| Receivables | $60M | $38M | $33M | $30M | $85M | $57M | $30M | $56M | $26M | $15M | $6M | $13M | |
| Inventory | $9M | $14M | $24M | $13M | $27M | $26M | $7M | $7M | $4M | $2M | $2M | $269.0K | |
| Prepaid Expense | · | $2M | $1M | $1M | · | · | · | · | $1M | $2M | $1M | $835.0K | |
| Other Current Assets | $6M | $9M | $3M | $2M | $4M | $4M | $5M | $11M | $2M | $2M | $2M | $2M | |
| Current Assets | $832M | $332M | $237M | $264M | $465M | $501M | $1.12B | $871M | $237M | $163M | $215M | $185M | |
| PP&E (Net) | $4M | $15M | $16M | $12M | $13M | $13M | $7M | $5M | $4M | $2M | $372.0K | $486.0K | |
| PP&E (Gross) | $10M | $23M | $22M | $23M | $29M | $20M | $10M | $8M | $6M | $3M | $3M | $3M | |
| Accum. Depreciation | $7M | $8M | $7M | $10M | $9M | $6M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Goodwill | $102M | $105M | $103M | $0 | $106M | $190M | $95M | $87M | $86M | $72M | $12M | $12M | |
| Intangibles | $225M | $267M | $300M | $342M | $377M | $595M | $210M | $220M | $229M | $205M | $48M | $51M | |
| Other Non-current Assets | $13M | $32M | $6M | $2M | $1M | $4M | $2M | $471.0K | $5M | $2M | $27.0K | $207.0K | |
| Total Assets | $1.56B | $942M | $787M | $763M | $1.30B | $1.36B | $1.49B | $1.26B | $671M | $602M | $503M | $258M | |
| Accounts Payable | $3M | $5M | $2M | $5M | $8M | $4M | $2M | $4M | $2M | $3M | $4M | $8M | |
| Accrued Liabilities | $31M | $28M | $12M | $16M | $18M | $19M | $9M | $19M | $7M | $6M | $5M | $5M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $225M | $213M | $202M | $334.0K | |
| Current Liabilities | $37M | $37M | $17M | $99M | $42M | $100M | $17M | $82M | $239M | $227M | $223M | $23M | |
| Capital Leases | $4M | $6M | $6M | $10M | $2M | $6M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $36M | $33M | $32M | $31M | $31M | $65M | $33M | $0 | · | · | · | $3M | |
| Other Non-current Liabilities | $17M | $30M | $28M | $28M | $22M | $31M | $22M | $951.0K | $4M | $687.0K | $297.0K | $770.0K | |
| Total Liabilities | $543M | $111M | $86M | $165M | $476M | $653M | $728M | $700M | $252M | $231M | $226M | $234M | |
| Total Debt | · | · | · | · | · | · | · | · | $225M | $213M | $202M | $334.0K | |
| Common Stock | $20.0K | $20.0K | $18.0K | $17.0K | $17.0K | $16.0K | $17.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | |
| Paid-in Capital | $401M | $337M | $199M | $148M | $373M | $318M | $367M | $791M | $798M | $770M | $662M | $681M | |
| Retained Earnings | $608M | $499M | $503M | $451M | $449M | $392M | $400M | $-229M | $-401M | $-431M | $-429M | $-659M | |
| AOCI | $8M | $-6M | $-817.0K | $-984.0K | $-917.0K | $-801.0K | $-216.0K | $-1M | $2M | $3M | $5M | $5M | |
| Stockholders' Equity | $1.02B | $830M | $701M | $597M | $821M | $710M | $767M | $561M | $400M | $341M | $237M | $26M | |
| Liabilities + Equity | $1.56B | $942M | $787M | $763M | $1.30B | $1.36B | $1.49B | $1.26B | $671M | $602M | $503M | $258M | |
| Shares Outstanding | 19,774,000 | 19,106,000 | 17,556,000 | 16,951,000 | 16,767,000 | 16,080,000 | 16,823,000 | 20,766,000 | 21,148,665 | 20,909,301 | 19,949,012 | 19,575,150 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34M | $35M | $37M | $52M | $51M | $26M | $18M | $13M | $11M | $11M | $3M | $3M | |
| Stock-based Comp | $47M | $41M | $26M | $60M | $39M | $31M | $25M | $21M | $25M | $19M | $12M | $11M | |
| Deferred Tax | $22M | $-16M | $10M | $30M | $-5M | $-17M | $75M | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | $47M | $23M | $17M | $16M | $12M | $11M | $2M | $2M | |
| Other Non-cash | $-178M | $41M | $-75M | $29M | $-60M | $1M | $-702M | $15M | $44M | $34M | $-203M | $-5M | |
| Operating Cash Flow | $49M | $97M | $50M | $138M | $79M | $55M | $-29M | $194M | $89M | $61M | $42M | $21M | |
| CapEx | $452.0K | $2M | $4M | $18M | $9M | $4M | $3M | $887.0K | $2M | $2M | $93.0K | $6.0K | |
| Investing Cash Flow | $-377M | $-144M | $-12M | $164M | $31M | $232M | $467M | $-423M | $-79M | $-134M | $-113M | $-2M | |
| Net Debt Issued | $0 | $0 | $-77M | $-261M | $-156M | $-222M | $-27M | $-218M | · | $0 | $0 | $-9M | |
| Stock Issued | $0 | $37M | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $15M | $0 | $0 | $0 | $0 | $78M | $453M | $123M | $2M | $4M | $489.0K | $68M | |
| Net Stock Activity | $-15M | $37M | · | $0 | $0 | $-78M | $-453M | $-123M | $-2M | $-4M | $-489.0K | $-68M | |
| Financing Cash Flow | $428M | $97M | $-60M | $-276M | $-138M | $-311M | $-485M | $329M | $-8M | $-5M | $8M | $130M | |
| Net Change in Cash | $103M | $49M | $-22M | $25M | · | · | · | · | $2M | $-79M | $-63M | $149M | |
| Taxes Paid | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $49M | $95M | $46M | $120M | $70M | $50M | $-32M | $193M | $91M | $61M | $42M | $21M | |
| Levered FCF | · | · | $46M | $120M | $46M | $42M | $-60M | $153M | · | · | · | $16M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.3% | -13.5% | 9.1% | 1.6% | 28.5% | 13.9% | 671.0% | 65.1% | 48.2% | 40.3% | 38.0% | 30.4% | |
| Net Margin | 46.4% | -2.4% | 39.7% | -17.0% | 20.6% | -1.6% | 523.2% | 57.0% | 8.9% | -1.5% | 319.6% | 18.6% | |
| Pretax Margin | 59.3% | 1.5% | 48.5% | 18.4% | 17.1% | -5.7% | 662.3% | 68.9% | 40.6% | 7.3% | 49.1% | 17.5% | |
| EBITDA Margin | 27.9% | 7.6% | 36.9% | 27.8% | 46.9% | 27.7% | 686.2% | 71.0% | 56.5% | 50.6% | 41.7% | 34.5% | |
| ROA | 10.0% | -0.47% | 6.7% | -3.2% | 4.3% | -0.21% | 45.7% | 14.8% | 2.0% | -0.30% | · | 6.6% | |
| ROE | 13.5% | -0.48% | 7.6% | -4.7% | 7.0% | -0.42% | 77.8% | 22.7% | 3.4% | -0.57% | · | 31.7% | |
| ROIC | 3.2% | 4.4% | 1.4% | -0.07% | 11.6% | 1.0% | 83.1% | 24.1% | 2.4% | -2.4% | 87.1% | 71.0% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.2 | 8.9 | 14.1 | 2.7 | 11.2 | 5.0 | 66.1 | 10.6 | 1.0 | 0.7 | · | 8.1 | |
| Quick Ratio | 21.2 | 7.9 | 12.1 | 2.5 | 10.2 | 4.7 | 61.3 | 9.4 | 1.0 | 0.7 | · | 7.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.6 | · | 0.0 | |
| Interest Coverage | · | · | 18.2 | 1.7 | 4.0 | 0.9 | 22.6 | 3.4 | · | · | · | 4.0 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | · | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | 1.1 | 1.7 | 3.1 | · | 11.0 | |
| Receivables Turnover | 5.5 | 4.7 | 4.1 | 3.4 | 3.9 | 4.3 | 2.8 | 6.2 | 7.0 | 10.4 | · | 8.7 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $51.44 | $43.46 | $39.92 | $35.25 | $48.97 | $44.12 | $45.61 | $27.01 | $18.90 | $16.32 | · | $1.34 | |
| Revenue / Share | $13.21 | $9.14 | $7.40 | $11.63 | $16.07 | $11.52 | $6.09 | $10.45 | $6.01 | $5.23 | $3.39 | $3.01 | |
| Cash Flow / Share | $2.43 | $5.31 | $2.79 | $8.17 | $4.57 | $3.37 | $-1.48 | $8.06 | $3.98 | $3.02 | $1.97 | $0.96 | |
| Cash / Share | $8.85 | $3.78 | $1.31 | $2.66 | $1.16 | $2.96 | $4.25 | $5.64 | $0.97 | $0.90 | · | $8.18 | |
| EPS (TTM) | $6.13 | $-0.22 | $2.94 | $-1.98 | $3.31 | $-0.18 | $31.85 | $5.96 | $0.53 | $-0.08 | $10.83 | $0.56 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.4% | 27.3% | -33.1% | -18.8% | 47.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.0% | -11.6% | -7.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $268M | $167M | $131M | $196M | $242M | $164M | $120M | $251M | $141M | $109M | $72M | $65M | |
| Net Income TTM | $124M | $-4M | $52M | $-33M | $57M | $-3M | $629M | $143M | $13M | $-2M | $230M | $12M | |
| Market Cap | $3.74B | $2.05B | $1.25B | $1.13B | $1.62B | $998M | $1.09B | $1.76B | $1.81B | $1.33B | · | $650M | |
| Enterprise Value | · | · | · | · | · | · | · | · | $1.83B | $1.40B | · | $483M | |
| P/E | 30.8 | -487.0 | 24.3 | -33.7 | 29.1 | -344.7 | 2.0 | 14.2 | 161.2 | -792.3 | 6.2 | 59.3 | |
| P/S | 13.9 | 12.2 | 9.5 | 5.8 | 6.7 | 6.1 | 9.1 | 7.0 | 12.8 | 12.2 | · | 10.1 | |
| P/B | 3.7 | 2.5 | 1.8 | 1.9 | 2.0 | 1.4 | 1.4 | 3.1 | 4.5 | 3.9 | · | 24.7 | |
| P / Tangible Book | 5.4 | 4.5 | 4.2 | 4.4 | 4.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | 75.7 | 21.1 | 25.3 | 8.2 | 20.5 | 18.3 | -37.3 | 9.1 | 19.3 | 21.0 | · | 31.6 | |
| P / FCF | 76.4 | 21.5 | 27.2 | 9.4 | 23.1 | 19.9 | -34.3 | 9.1 | 19.8 | 21.7 | · | 31.6 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 22.9 | 25.3 | · | 21.7 | |
| EV / FCF | · | · | · | · | · | · | · | · | 20.0 | 22.8 | · | 23.5 | |
| EV / Revenue | · | · | · | · | · | · | · | · | 13.0 | 12.8 | · | 7.5 | |
| Earnings Yield | 3.2% | -0.21% | 4.1% | -3.0% | 3.4% | -0.29% | 49.0% | 7.0% | 0.62% | -0.13% | 16.0% | 1.7% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $64M | $52M | $60M | $115M | $48M | $45M | $43M | $52M | $42M | $31M | $28M | $33M | $26M | $44M | $50M | $59M | |
| R&D Expense | $15M | $2M | $4M | $21M | $7M | $50M | $4M | $6M | $5M | $6M | $5M | $6M | $7M | $7M | $9M | $9M | |
| SG&A Expense | $29M | $21M | $25M | $28M | $20M | $19M | $26M | $24M | $18M | $11M | $16M | $15M | $11M | $11M | $31M | $15M | |
| Operating Income | $9M | $17M | $14M | $55M | $8M | $-36M | $-10M | $3M | $-19M | $3M | $-3M | $3M | $-2M | $14M | $-20M | $12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $141.0K | · | $1.0K | $284.0K | $240.0K | · | $332.0K | |
| Interest Income | $7M | $7M | $6M | $4M | $2M | $2M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $591.0K | |
| Other Non-op | $3M | $-1M | $1M | $-443.0K | $1M | $-3M | $25M | $-9M | $-34M | $-2M | $3M | $-4M | $-873.0K | $603.0K | $-793.0K | $677.0K | |
| Pretax Income | $64M | $-24M | $57M | $141M | $11M | $-50M | $-39M | $-6M | $-65M | $113M | $17M | $-12M | $3M | $56M | $24M | $12M | |
| Income Tax | $16M | $-11M | $12M | $24M | $6M | $-8M | $-8M | $833.0K | $-13M | $27M | $-1M | $-2M | $881.0K | $12M | $39M | $3M | |
| Net Income | $49M | $-13M | $45M | $117M | $5M | $-42M | $-31M | $-7M | $-52M | $86M | $18M | $-10M | $2M | $42M | $-17M | $404.0K | |
| EPS (Basic) | $2.42 | $-0.67 | $2.41 | $5.99 | $0.25 | $-2.21 | $-1.81 | $-0.39 | $-2.88 | $4.86 | $1.02 | $-0.59 | $0.13 | $2.46 | $-1.04 | $0.02 | |
| EPS (Diluted) | $2.22 | $-0.67 | $2.42 | $5.68 | $0.24 | $-2.21 | $-1.70 | $-0.39 | $-2.88 | $4.75 | $1.07 | $-0.59 | $0.13 | $2.33 | $-1.04 | $0.02 | |
| Shares (Basic) | 20,063,000 | 19,883,000 | · | 19,578,000 | 19,327,000 | 19,191,000 | · | 18,419,000 | 18,028,000 | 17,732,000 | · | 17,380,000 | 17,276,000 | 17,063,000 | 16,890,000 | 16,888,000 | |
| Shares (Diluted) | 21,837,000 | 19,883,000 | · | 20,629,000 | 19,926,000 | 19,191,000 | · | 18,419,000 | 18,028,000 | 18,122,000 | · | 17,380,000 | 17,730,000 | 17,974,000 | · | 17,132,000 | |
| EBITDA | $9M | $26M | · | $55M | $8M | $-27M | · | $3M | $-19M | $12M | · | $3M | $-2M | $24M | · | $636.0K |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $115M | $175M | $139M | $68M | $48M | $72M | $64M | $18M | $50M | · | $19M | $28M | $89M | · | $4M | |
| Short-term Investments | $351M | $664M | $559M | $525M | $177M | $161M | $184M | $156M | $209M | $260M | · | $171M | $191M | $194M | · | $117M | |
| Receivables | $67M | $53M | $60M | $58M | $41M | $38M | $38M | $34M | $37M | $28M | · | $36M | $28M | $29M | · | $65M | |
| Inventory | $10M | $13M | $9M | $12M | $15M | $15M | $14M | $17M | $19M | $21M | · | $25M | $27M | $14M | · | $22M | |
| Prepaid Expense | · | · | · | · | · | · | · | $2M | $2M | $1M | · | · | · | · | · | · | |
| Other Current Assets | $6M | $6M | $6M | $7M | $5M | $13M | $9M | $20M | $7M | $7M | · | $2M | $3M | $2M | · | $11M | |
| Current Assets | $1.46B | $865M | $832M | $754M | $353M | $309M | $332M | $309M | $312M | $369M | · | $254M | $277M | $328M | · | $220M | |
| PP&E (Net) | $3M | $3M | $4M | $3M | $4M | $4M | $15M | $15M | $15M | $15M | · | $16M | $11M | $12M | · | $33M | |
| PP&E (Gross) | · | · | $10M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $102M | $102M | $102M | $102M | $102M | $102M | $105M | $105M | $105M | $105M | · | $104M | $106M | $106M | $0 | $181M | |
| Intangibles | $209M | $217M | $225M | $234M | $250M | $258M | $267M | $275M | $283M | $291M | · | $315M | $325M | $334M | · | $517M | |
| Other Non-current Assets | $12M | $13M | $13M | $3M | $9M | $8M | $32M | $8M | $12M | $11M | · | $8M | $4M | $5M | · | $6M | |
| Total Assets | $2.19B | $1.53B | $1.56B | $1.48B | $949M | $905M | $942M | $955M | $866M | $914M | · | $769M | $758M | $811M | · | $1.05B | |
| Accounts Payable | $9M | $5M | $3M | $4M | $9M | $5M | $5M | $5M | $2M | $2M | · | $2M | $10M | $6M | · | $16M | |
| Accrued Liabilities | $32M | $32M | $31M | $24M | $17M | $24M | $28M | $16M | $12M | $12M | · | $11M | $7M | $15M | · | $19M | |
| Current Liabilities | $47M | $41M | $37M | $31M | $65M | $59M | $37M | $25M | $19M | $18M | · | $16M | $29M | $99M | · | $135M | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $4M | $6M | $6M | $6M | $5M | · | $6M | $11M | $11M | · | $35M | |
| Deferred Tax | $22M | $23M | $36M | $23M | $32M | $29M | $33M | $46M | $30M | $51M | · | $33M | $28M | $30M | · | $30M | |
| Other Non-current Liabilities | $17M | $17M | $17M | $20M | $14M | $14M | $30M | $30M | $29M | $28M | · | $44M | $22M | $22M | $28M | $22M | |
| Total Liabilities | $1.22B | $535M | $543M | $527M | $120M | $110M | $111M | $114M | $91M | $107M | · | $101M | $93M | $165M | · | $234M | |
| Long-term Debt | $1.13B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $19.0K | $19.0K | $18.0K | · | $18.0K | $17.0K | $17.0K | · | $17.0K | |
| Paid-in Capital | $380M | $397M | $401M | $363M | $359M | $341M | $337M | $309M | $239M | $218M | · | $184M | $171M | $154M | · | $349M | |
| Retained Earnings | $583M | $595M | $608M | $578M | $461M | $457M | $499M | $530M | $537M | $589M | · | $485M | $495M | $493M | · | $468M | |
| AOCI | $4M | $5M | $8M | $9M | $8M | $-2M | $-6M | $2M | $-935.0K | $-910.0K | · | $-944.0K | $-967.0K | $-935.0K | · | $-1M | |
| Stockholders' Equity | $968M | $997M | $1.02B | $950M | $829M | $796M | $830M | $841M | $775M | $807M | $701M | $668M | $665M | $646M | $597M | $816M | |
| Liabilities + Equity | $2.19B | $1.53B | $1.56B | $1.48B | $949M | $905M | $942M | $955M | $866M | $914M | · | $769M | $758M | $811M | · | $1.05B | |
| Shares Outstanding | 19,920,000 | 20,029,000 | 19,774,000 | 19,656,000 | 19,411,000 | 19,276,000 | 19,106,000 | 18,760,000 | 18,103,000 | 17,924,000 | 17,556,000 | 17,421,000 | 17,352,000 | 17,134,000 | 16,951,000 | 16,894,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $11M | $13M | |
| Stock-based Comp | $14M | $11M | $14M | $15M | $10M | $8M | $8M | $15M | $11M | $7M | $6M | $7M | $7M | $6M | $29M | $13M | |
| Other Non-cash | · | $43M | · | · | · | $400.0K | · | · | · | $-84M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $24M | $49M | $46M | $13M | $16M | $-25M | $28M | $37M | $13M | $19M | $8M | $8M | $-82.0K | $34M | $53M | $20M | |
| CapEx | $26.0K | $228.0K | $9.0K | $15.0K | $214.0K | $214.0K | $712.0K | $596.0K | $408.0K | $105.0K | $417.0K | $487.0K | $203.0K | $2M | $2M | $4M | |
| Investing Cash Flow | $321M | $-94M | $-18M | $-353M | $-11M | $5M | $-39M | $-47M | $-55M | $-4M | $-10M | $-20M | $8M | $11M | $-7M | $19M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $0 | · | · | · | $3M | · | · | · | $0 | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $15M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $546M | $-14M | $8M | $410M | $15M | $-5M | $20M | $55M | $9M | $12M | $5M | $3M | $-68M | $-775.0K | $-5M | $-41M | |
| Net Change in Cash | $892M | $-60M | · | · | $20M | $-24M | $9M | $45M | $-32M | $27M | $3M | $-9M | $-60M | $44M | $41M | $-1M | |
| Free Cash Flow | · | $48M | · | · | · | $-26M | · | · | · | $19M | · | · | · | $32M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $19M | · | · | · | $31M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.5% | 33.6% | · | 47.6% | 17.7% | -79.9% | · | 6.1% | -46.0% | 9.7% | · | 9.4% | -7.5% | 32.3% | · | 0.96% | |
| Net Margin | 76.2% | -25.8% | · | 101.6% | 10.2% | -93.6% | · | -13.8% | -125.0% | 278.1% | · | -31.3% | 8.7% | 95.4% | · | 0.61% | |
| Pretax Margin | 101.0% | -46.9% | · | 122.2% | 23.6% | -110.7% | · | -12.2% | -157.4% | 366.2% | · | -37.0% | 12.0% | 126.3% | · | 1.3% | |
| EBITDA Margin | 13.5% | 49.5% | · | 47.6% | 17.7% | -60.5% | · | 6.1% | -46.0% | 37.9% | · | 9.4% | -7.5% | 53.9% | · | 0.96% | |
| ROA | 3.1% | -1.1% | · | 9.7% | 0.53% | -4.7% | · | -0.83% | -6.4% | 10.0% | · | -1.1% | 0.25% | 4.4% | · | 0.03% | |
| ROE | 5.4% | -1.5% | · | 13.1% | 0.60% | -5.3% | · | -0.95% | -7.2% | 11.9% | · | -1.4% | 0.31% | 5.8% | · | 0.05% | |
| ROIC | 0.67% | 0.96% | · | 4.8% | 0.44% | -3.9% | · | 0.42% | -2.0% | 0.28% | · | 0.39% | -0.22% | 1.7% | · | 0.04% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.2 | 21.3 | · | 24.7 | 5.5 | 5.3 | · | 12.5 | 16.8 | 20.7 | · | 16.2 | 9.4 | 3.3 | · | 1.6 | |
| Quick Ratio | 30.5 | 20.5 | · | 23.6 | 4.4 | 4.2 | · | 10.3 | 14.2 | 19.0 | · | 14.4 | 8.4 | 3.2 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 21.2 | · | 3078.0 | -7.0 | 59.2 | · | 1.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.2 | 1.1 | · | 2.5 | 1.2 | 1.4 | · | 1.5 | 1.3 | 1.1 | · | 0.6 | 0.6 | 1.2 | · | 1.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $48.57 | $49.79 | · | $48.34 | $42.68 | $41.27 | · | $44.84 | $42.82 | $45.00 | · | $38.34 | $38.32 | $37.72 | · | $48.32 | |
| Revenue / Share | $2.92 | $2.60 | · | $5.60 | $2.39 | $2.36 | · | $2.81 | $2.30 | $1.71 | · | $1.89 | $1.49 | $2.45 | · | $3.86 | |
| Cash Flow / Share | · | $2.45 | · | · | · | $-1.33 | · | · | · | $1.03 | · | · | · | $1.89 | · | · | |
| Cash / Share | $50.54 | $5.75 | · | $7.09 | $3.49 | $2.49 | · | $3.39 | $1.00 | $2.79 | · | $1.11 | $1.64 | $5.18 | · | $0.24 | |
| EPS (TTM) | $9.65 | $7.67 | · | $2.01 | $-4.06 | $-7.18 | · | $2.55 | $2.35 | $5.36 | · | $0.83 | $1.44 | $1.26 | · | $-1.27 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $291M | $274M | · | $251M | $188M | $181M | · | $152M | $133M | $118M | · | $154M | $180M | $204M | · | $183M | |
| Net Income TTM | $197M | $154M | · | $49M | $-76M | $-133M | · | $45M | $42M | $96M | · | $16M | $27M | $24M | · | $-21M | |
| Market Cap | $6.30B | $4.00B | · | $3.48B | $2.21B | $2.03B | · | $1.88B | $1.53B | $1.31B | · | $1.04B | $1.25B | $1.26B | · | $908M | |
| P/E | 32.8 | 26.0 | · | 88.1 | -28.0 | -14.6 | · | 39.3 | 35.9 | 13.6 | · | 72.2 | 50.1 | 58.4 | · | -42.3 | |
| P/S | 21.7 | 14.6 | · | 13.9 | 11.8 | 11.2 | · | 12.3 | 11.4 | 11.1 | · | 6.8 | 7.0 | 6.2 | · | 5.0 | |
| P/B | 6.5 | 4.0 | · | 3.7 | 2.7 | 2.5 | · | 2.2 | 2.0 | 1.6 | · | 1.6 | 1.9 | 2.0 | · | 1.1 | |
| P / Tangible Book | 9.6 | 5.9 | · | 5.7 | 4.6 | 4.7 | · | 4.1 | 3.9 | 3.2 | · | 4.2 | 5.4 | 6.1 | · | 7.7 | |
| P / Cash Flow | · | 82.1 | · | · | · | -79.6 | · | · | · | 69.9 | · | · | · | 37.1 | · | · | |
| Earnings Yield | 3.0% | 3.8% | · | 1.1% | -3.6% | -6.8% | · | 2.5% | 2.8% | 7.3% | · | 1.4% | 2.0% | 1.7% | · | -2.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $268M | $167M | $131M | $196M | $242M |
| Faaliyet Kâr Marjı % | 15.3% | -13.5% | 9.1% | 1.6% | 28.5% |
| Net Gelir | $124M | $-4M | $52M | $-33M | $57M |
| Seyreltilmiş Hisse Başı Kâr | $6.13 | $-0.22 | $2.94 | $-1.98 | $3.31 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 22.2 | 8.9 | 14.1 | 2.7 | 11.2 |
| Cari Oran | 21.2 | 7.9 | 12.1 | 2.5 | 10.2 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $49M | $95M | $46M | $120M | $70M |
Kurumsal Sahipler (13F) 443 dosya · $7.3B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
443
Tutulan Değer
$7.3B
Yeni pozisyonlar
100
Çıkan pozisyonlar
31
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 100 (+31 önceki Ç'ye göre) | 31 (-13 önceki Ç'ye göre) | 153 (+23 önceki Ç'ye göre) | 112 (+4 önceki Ç'ye göre) | +1.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $980.193.825 | 3.100.996 | 13,35% | Hisse senetleri |
| VANGUARD GROUP INC | $392.110.761 | 2.073.892 | 5,34% | Hisse senetleri |
| Invesco Ltd. | $379.827.651 | 1.201.644 | 5,17% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $359.810.304 | 1.138.316 | 4,90% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $275.298.586 | 870.950 | 3,75% | Hisse senetleri |
| STATE STREET CORP | $261.251.813 | 826.539 | 3,56% | Hisse senetleri |
| FMR LLC | $241.122.115 | 762.827 | 3,28% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $237.713.677 | 752.044 | 3,24% | Hisse senetleri |
| CONGRESS ASSET MANAGEMENT CO | $208.591.268 | 659.911 | 2,84% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $201.622.937 | 1.009.891 | 2,75% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $186.213.020 | 589.020 | 2,54% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $179.656.000 | 568.371 | 2,45% | Hisse senetleri |
| Chicago Capital, LLC | $174.935.212 | 553.435 | 2,38% | Hisse senetleri |
| Stephens Investment Management Group LLC | $150.335.249 | 475.609 | 2,05% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $135.699.871 | 429.314 | 1,85% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $118.774.611 | 375.762 | 1,62% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $116.953.300 | 3.700 | 1,59% | Alım opsiyonu |
| GOLDMAN SACHS GROUP INC | $102.174.511 | 323.245 | 1,39% | Hisse senetleri |
| LOOMIS SAYLES & CO L P | $92.236.642 | 291.805 | 1,26% | Hisse senetleri |
| RICE HALL JAMES & ASSOCIATES, LLC | $85.360.737 | 270.052 | 1,16% | Hisse senetleri |
| Ranger Investment Management, L.P. | $81.423.520 | 257.596 | 1,11% | Hisse senetleri |
| NORTHERN TRUST CORP | $81.358.089 | 257.389 | 1,11% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $80.212.263 | 253.764 | 1,09% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $78.899.541 | 249.611 | 1,07% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $78.502.532 | 248.355 | 1,07% | Hisse senetleri |
| MORGAN STANLEY | $63.439.444 | 200.699 | 0,86% | Hisse senetleri |
| NEXT CENTURY GROWTH INVESTORS LLC | $62.757.140 | 198.542 | 0,85% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $61.080.599 | 193.238 | 0,83% | Hisse senetleri |
| Aberdeen Group plc | $54.519.204 | 172.480 | 0,74% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $53.845.507 | 170.349 | 0,73% | Hisse senetleri |
| ASHFORD CAPITAL MANAGEMENT INC | $53.809.897 | 170.236 | 0,73% | Hisse senetleri |
| Private Capital Management, LLC | $52.475.997 | 166.016 | 0,71% | Hisse senetleri |
| VILLERE ST DENIS J & CO LLC | $49.153.891 | 155.506 | 0,67% | Hisse senetleri |
| Granahan Investment Management, LLC | $46.538.247 | 147.231 | 0,63% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $45.177.479 | 142.926 | 0,62% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $43.385.881 | 137.258 | 0,59% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42.503.090 | 212.888 | 0,58% | Hisse senetleri |
| Bank of New York Mellon Corp | $41.429.372 | 131.068 | 0,56% | Hisse senetleri |
| Impax Asset Management Group plc | $41.091.700 | 130.000 | 0,56% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $40.165.872 | 127.071 | 0,55% | Hisse senetleri |
| UBS Group AG | $39.408.205 | 124.674 | 0,54% | Hisse senetleri |
| Fisher Asset Management, LLC | $38.386.026 | 121.440 | 0,52% | Hisse senetleri |
| Russell Investments Group, Ltd. | $38.027.274 | 120.304 | 0,52% | Hisse senetleri |
| ROYAL BANK OF CANADA | $37.638.000 | 119.073 | 0,51% | Hisse senetleri |
| Driehaus Capital Management LLC | $37.455.717 | 118.497 | 0,51% | Hisse senetleri |
| Penn Capital Management Company, LLC | $31.748.435 | 100.337 | 0,43% | Hisse senetleri |
| Legal & General Group Plc | $31.212.622 | 98.746 | 0,43% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $30.967.653 | 97.971 | 0,42% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $29.735.218 | 94.072 | 0,40% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $28.730.368 | 90.893 | 0,39% | Hisse senetleri |
Aktivistler ve %5+ sahipler 18 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated ×10 başvurular | 01 Mayıs 2026 | 47,00% | İlk başvuru | M&A / satış | SEC |
| David M. Knott, Dorset Management Corporation ×8 başvurular | 24 Mayıs 2016 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Ligand Pharmaceuticals Incorporated (2) ×4 başvurular | 28 Ocak 2010 | · | İlk başvuru | · | SEC |
| Noonday Asset Management, L.P., Noonday G.P. (U.S.), L.L.C., Noonday Capital, L.L.C., David I. Cohen, Saurabh K. Mittal, Noonday Capital Partners, L.L.C., Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Tinicum Partners, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital Management, L.L.C., Farallon Partners, L.L.C., Chun R. Ding, William F. Duhamel, Richard B. Fried, Monica R. Landry, Douglas M. MacMahon, William F. Mellin, Stephen L. Millham, Jason E. Moment, Rajiv A. Patel, Derek C. Schrier, Thomas F. Steyer, Mark C. Wehrly | 30 Mart 2007 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 28 Mart 2007 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 12 Şubat 2007 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 18 Eylül 2006 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 10 Ağustos 2006 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 05 Aralık 2005 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 16 Kasım 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 07 Kasım 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 26 Ekim 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 12 Ekim 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 30 Eylül 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 23 Eylül 2005 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi | 22 Temmuz 2003 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 17 Haziran 2003 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 22 Mart 2002 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 47 içeriden öğrenenler · 18 yöneticiler · 23 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Todd C Davis | Chief Executive Officer | 30 Haziran 2026 J | 199.513 | 0 | 0 | $0 |
| David E Robinson | Pres, CEO & Chairman | 10 Mart 2006 A | 411.725 | 0 | 0 | $0 |
| Octavio Espinoza | Chief Financial Officer | 12 Ağustos 2026 M | 27.696 | 0 | 14 | $-13.031.451 |
| Nishan M Desilva | VP, Finance & Strategy and CFO | 14 Mayıs 2015 M | 22.282 | 0 | 0 | $0 |
| John P Sharp | VP Finance and CFO | 12 Şubat 2014 M | 17.667 | 0 | 0 | $0 |
| Paul V Maier | Sr. V-P, CFO | 20 Kasım 2006 M | 84.951 | 0 | 0 | $0 |
| Matthew E Korenberg | President & COO | 23 Eylül 2024 M | 50.777 | 0 | 0 | $0 |
| Andrew Reardon | CLO & Secretary | 03 Eylül 2026 S | 36.514 | 0 | 54 | $-8.771.644 |
| Melanie J Herman | Director of Accounting | 30 Haziran 2016 J | 3.454 | 0 | 0 | $0 |
| Syed Kazmi | VP, Bus. Dev. & Strategic Plan | 09 Şubat 2012 A | 18.230 | 0 | 0 | $0 |
| Martin Meglasson | V-P, Discovery Research | 11 Mayıs 2010 P | 102.250 | 0 | 0 | $0 |
| Zofia E Dziewanowska | VP, Clinical Research | 25 Şubat 2009 S | 33.977 | 0 | 0 | $0 |
| William A Petttit | Sr. V-P, HR and Administration | 15 Aralık 2006 M | 889 | 0 | 0 | $0 |
| Eric S Groves | V-P, Project Management | 15 Aralık 2006 M | 5.127 | 0 | 0 | $0 |
| Andres Negro-Vilar | Exe V-P, R & D, CSO | 14 Aralık 2006 M | 7.233 | 0 | 0 | $0 |
| Taylor Crouch | Sr. V-P, Ops & Pres. Int'l | 05 Aralık 2006 M | 0 | 0 | 0 | $0 |
| Tod Mertes | V-P, Controller & Treasurer | 10 Mart 2006 A | 1.476 | 0 | 0 | $0 |
| James J Litalien | Sr. V-P, Reg Affairs & Comp. | 10 Mart 2006 A | 0 | 0 | 0 | $0 |
| Martine Zimmermann | Yönetim kurulu üyesi | 22 Eylül 2026 F | 3.782 | 0 | 1 | $-342.000 |
| Jason Haas | Yönetim kurulu üyesi | 12 Ağustos 2026 M | 3.981 | 0 | 3 | $-3.741.401 |
| Stephen L Sabba | Yönetim kurulu üyesi | 16 Haziran 2026 M | 33.629 | 0 | 3 | $-1.162.551 |
| John L Lamattina | Yönetim kurulu üyesi | 10 Haziran 2026 S | 26.969 | 0 | 7 | $-2.444.203 |
| Nancy Ryan Gray | Yönetim kurulu üyesi | 05 Haziran 2026 A | 8.930 | 0 | 2 | $-1.350.012 |
| Jason Aryeh | Yönetim kurulu üyesi | 05 Haziran 2026 A | 102.580 | 0 | 2 | $-1.250.000 |
| John W Kozarich | Yönetim kurulu üyesi | 05 Haziran 2026 A | 42.622 | 0 | 43 | $-1.195.652 |
| John L Higgins | Yönetim kurulu üyesi | 28 Aralık 2022 F | 417.695 | 0 | 0 | $0 |
| David M Knott | Yönetim kurulu üyesi | 17 Ağustos 2015 S | 66.152 | 0 | 0 | $0 |
| Steven J Burakoff | Yönetim kurulu üyesi | 29 Mayıs 2009 A | 15.000 | 0 | 0 | $0 |
| Bruce Peacock | Yönetim kurulu üyesi | 23 Aralık 2008 A | 10.000 | 0 | 0 | $0 |
| Ligand Pharmaceuticals Incorporated | Yönetim kurulu üyesi | 04 Ağustos 2008 A | 10.000 | 0 | 0 | $0 |
| Jeffrey R Perry | Yönetim kurulu üyesi | 29 Mayıs 2008 A | 33.953 | 0 | 0 | $0 |
| Elizabeth M Greetham | Yönetim kurulu üyesi | 29 Mayıs 2008 A | 10.000 | 0 | 0 | $0 |
| Henry F Blissenbach | Yönetim kurulu üyesi | 02 Nisan 2007 M | 15.005 | 0 | 0 | $0 |
| Brigette Roberts | Yönetim kurulu üyesi | 03 Ocak 2007 A | 2.378 | 0 | 0 | $0 |
| Irving S Johnson | Yönetim kurulu üyesi | 03 Ocak 2007 A | 22.929 | 0 | 0 | $0 |
| Alexander D Cross | Yönetim kurulu üyesi | 03 Ocak 2007 A | 26.335 | 0 | 0 | $0 |
| John Groom | Yönetim kurulu üyesi | 27 Eylül 2006 A | 16.237 | 0 | 0 | $0 |
| Carl C Peck | Yönetim kurulu üyesi | 27 Eylül 2006 A | 8.378 | 0 | 0 | $0 |
| Michael A Rocca | Yönetim kurulu üyesi | 27 Eylül 2006 A | 11.676 | 0 | 0 | $0 |
| Jennifer R. Cochran | · | 01 Kasım 2022 D | 1.161 | 0 | 0 | $0 |
| Sarah Boyce | · | 01 Kasım 2022 D | 2.892 | 0 | 0 | $0 |
| Sunil Patel | · | 01 Kasım 2022 D | 28.820 | 0 | 0 | $0 |
| Charles S Berkman | · | 01 Kasım 2022 D | 23.825 | 0 | 0 | $0 |
| Matthew W Foehr | · | 01 Kasım 2022 D | 162.187 | 0 | 0 | $0 |
| Loeb, Daniel S. | · | 26 Mart 2007 S | 2.027.378 | 0 | 0 | $0 |
| Warner R Broaddus | · | 17 Kasım 2006 M | 0 | 0 | 0 | $0 |
| Giambattista Aliprandi | · | 01 Haziran 2004 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 62 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 3,50% | 63.460 SH | 02 Ekim 2026 | Günlük |
| PSCH · Invesco Exchange-Traded Fund Trust … | 3,30% | 18.959 SH | 02 Ekim 2026 | Günlük |
| CSMD · Professionally Managed Portfolios | 2,64% | 41.620 NS | 31 Temmuz 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 1,94% | 184.968 SH | 02 Ekim 2026 | Günlük |
| BBP · ETFis Series Trust I | 1,55% | 5.310 NS | 31 Temmuz 2026 | N-PORT |
| IHE · iShares Trust | 1,32% | 74.179 SH | 11 Eylül 2026 | Günlük |
| PILL · Direxion Shares ETF Trust | 1,32% | 947 NS | 31 Temmuz 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1,30% | 5.132 SH | 02 Ekim 2026 | Günlük |
| CAFG · Pacer Funds Trust | 0,96% | 1.010 NS | 31 Temmuz 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,69% | 23.854 SH | 19 Ağustos 2026 | Günlük |
| JSML · Janus Detroit Street Trust | 0,62% | 7.791 NS | 31 Temmuz 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,62% | 27.765 NS | 31 Temmuz 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,56% | 422 SH | 02 Ekim 2026 | Günlük |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,46% | 6.128 SH | 02 Ekim 2026 | Günlük |
| SAWS · ETF Series Solutions | 0,41% | 111 NS | 31 Temmuz 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,41% | 1.422 SH | 02 Ekim 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,38% | 2.983 SH | 02 Ekim 2026 | Günlük |
| IWO · iShares Trust | 0,38% | 189.025 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,37% | 21.495 SH | 19 Ağustos 2026 | Günlük |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,35% | 7.180 NS | 31 Temmuz 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,34% | 70.067 SH | 19 Ağustos 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,29% | 13.798 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,25% | 763 NS | 31 Temmuz 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 5.287 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,19% | 513.328 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,19% | 115.596 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,19% | 9.615 NS | 31 Temmuz 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 15.869 NS | 31 Temmuz 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,13% | 277.215 SH | 19 Ağustos 2026 | Günlük |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,13% | 2.515 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,12% | 63.276 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,12% | 3.939 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,09% | 8.071 SH | 02 Ekim 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,09% | 58.421 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,08% | 9.216 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 229.811 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,07% | 436.655 SH | 19 Ağustos 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 3.827 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,05% | 1.199 SH | 11 Eylül 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 271 SH | 02 Ekim 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,03% | 42.028 NS | 31 Temmuz 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,02% | 1.274 SH | 02 Ekim 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,02% | 8.647 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 1.810 NS | 31 Temmuz 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 0,01% | 123 SH | 02 Ekim 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 605.870 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 16.031 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.642 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,01% | 4.432 SH | 19 Ağustos 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,01% | 3.926 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 27.511 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,01% | 632 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 5.857 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 5.438 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,00% | 54 NS | 31 Temmuz 2026 | N-PORT |
| IJR · iShares Trust | · | 1.223.008 SH | 10 Eylül 2026 | Günlük |
| IJT · iShares Trust | · | 189.600 SH | 09 Eylül 2026 | Günlük |
| XJR · iShares Trust | · | 2.771 SH | 31 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 887 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 1.532 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 28.204 SH | 11 Eylül 2026 | Günlük |
| SMMV · iShares Trust | · | 926 SH | 19 Ağustos 2026 | Günlük |
LGND Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 16 analist
AL
Medyan hedef
$345.00
+13,9%
7 43,8%
Güçlü Al
8 50,0%
Al
1 6,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
12 analist · 2026-10-01Ortalama hedef $344.25 +13,6%
Şimdi
Mevcut fiyat $302.96
Düşük$247.00
Ortalama$344.25
Yüksek$397.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | · |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| BLTE | $6.29B | -69.2 | · | · | -16.9% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| DFTX | $1.32B | -6.5 | 212.0% | · | -71.0% | · |
| MANE | · | · | · | · | 82.6% | · |
| EWTX | $2.64B | -15.2 | · | · | -30.2% | · |
| INDV | · | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 7, 2026